‘I’m quite frankly baffled’: Teva’s $235M overturn in GSK patent case has judge ‘bewildered’ FiercePharma
Facing claims it induced doctors to prescribe a generic version of GlaxoSmithKline’s Coreg that violated its patents, Teva was hit with a hefty $235 million penalty …